Learn About Papillary Thyroid Cancer

View Main Condition: Thyroid Cancer

What is the definition of Papillary Thyroid Cancer?

Papillary carcinoma of the thyroid is the most common cancer of the thyroid gland. The thyroid gland is located in front of the lower neck.

What are the alternative names for Papillary Thyroid Cancer?

Papillary carcinoma of the thyroid; Papillary thyroid cancer; Papillary thyroid carcinoma

What are the causes of Papillary Thyroid Cancer?

About 85% of all thyroid cancers diagnosed in the United States are the papillary carcinoma type. It is more common in women than in men. It may occur in childhood, but is most often seen in adults between ages 20 and 60.

The cause of this cancer is not known. A genetic defect or family history of the disease may be a risk factor.

Radiation increases the risk for developing thyroid cancer. Exposure may occur from:

  • High-dose external radiation treatments to the neck, especially during childhood, used to treat childhood cancer or some noncancerous childhood conditions
  • Radiation exposure from nuclear plant disasters

Radiation given through a vein (through an IV) during medical tests and treatments does not increase the risk for developing thyroid cancer.

What are the symptoms of Papillary Thyroid Cancer?

Thyroid cancer often begins as a small lump (nodule) in the thyroid gland.

While some small lumps may be cancer, most (90%) thyroid nodules are harmless and are not cancerous.

Most of the time, there are no other symptoms.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Papillary Thyroid Cancer?

Thyroid cancer treatment may include:

  • Surgery
  • Radioactive iodine therapy
  • Thyroid suppression therapy (thyroid hormone replacement therapy)
  • External beam radiation therapy (EBRT)

Surgery is done to remove as much of the cancer as possible. The bigger the lump, the more of the thyroid gland must be removed. Often, the entire gland is taken out.

After the surgery, you may receive radioiodine therapy, which is often taken by mouth. This substance kills any remaining thyroid tissue. It also helps make medical images clearer, so doctors can see if there is any cancer left behind or if it comes back later.

Further management of your cancer will depend on many factors such as:

  • Size of any tumor present
  • Location of the tumor
  • Growth rate of the tumor
  • Symptoms you may have
  • Your own preferences

If surgery is not an option, external radiation therapy can be useful.

After surgery or radioiodine therapy, you will need to take medicine called levothyroxine for the rest of your life. This replaces the hormone the thyroid would normally make.

Your provider will likely have you take a blood test every several months to check thyroid hormone levels. Other follow-up tests that may be done after treatment for thyroid cancer include:

  • Ultrasound of the thyroid
  • An imaging test called a radioactive iodine (I-131) uptake scan
  • Repeat FNAB
Who are the top Papillary Thyroid Cancer Local Doctors?
Elite in Papillary Thyroid Cancer
Otolaryngology
Elite in Papillary Thyroid Cancer
Otolaryngology

Mskcc Surgery Group

1133 York Ave, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Ian Ganly is an Otolaryngologist in New York, New York. Dr. Ganly is rated as an Elite provider by MediFind in the treatment of Papillary Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Tongue Cancer, Thyroidectomy, and Laryngectomy.

Elite in Papillary Thyroid Cancer
Otolaryngology
Elite in Papillary Thyroid Cancer
Otolaryngology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Languages Spoken:
English
Offers Telehealth

Mark Zafereo is an Otolaryngologist in Houston, Texas. Dr. Zafereo is rated as an Elite provider by MediFind in the treatment of Papillary Thyroid Cancer. His top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Laryngectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Ashok R. Shaha
Elite in Papillary Thyroid Cancer
General Surgery
Elite in Papillary Thyroid Cancer
General Surgery

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Ashok Shaha is a General Surgeon in New York, New York. Dr. Shaha is rated as an Elite provider by MediFind in the treatment of Papillary Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

What are the support groups for Papillary Thyroid Cancer?

You can ease the stress of illness by joining a cancer support group. Sharing with others who have common experiences and problems can help you not feel alone.

What is the outlook (prognosis) for Papillary Thyroid Cancer?

The survival rate for papillary thyroid cancer is excellent. More than 90% of adults with this cancer survive at least 10 to 20 years. The prognosis is better for people who are younger than 40 and for those with smaller tumors.

The following factors may decrease the survival rate:

  • Older than 55 years of age
  • Cancer that has spread to distant parts of the body
  • Cancer that has spread to soft tissue around the thyroid
  • Large tumor
What are the possible complications of Papillary Thyroid Cancer?

Complications include:

  • Accidental removal of the parathyroid glands, which help regulate blood calcium levels
  • Damage to the nerve that controls the vocal cords
  • Spreading of cancer to lymph nodes (rare)
  • Spreading of cancer to other sites (metastasis)
When should I contact a medical professional for Papillary Thyroid Cancer?

Contact your provider if you have a lump in your neck.

What are the latest Papillary Thyroid Cancer Clinical Trials?
The Role of Environmental Factors in Thyroid Cancer

Summary: Thyroid cancer incidence has been steadily increasing and has nearly tripled since the 1970's in the US and worldwide. Early detection of small, papillary thyroid cancers using high quality diagnostic imaging explains only about 50% of this increased incidence, suggesting that there is a true increase in the occurrence of thyroid cancer and that changes in the prevalence of environmental risk fact...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Studies on Thyroid Nodules and Thyroid Cancer

Summary: Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Ot...

Who are the sources who wrote this article ?

Published Date: March 31, 2024
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 09/24/2025.

What are the references for this article ?

NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines) website. Thyroid carcinoma, Version 2.2024 - March 12, 2024. www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed May 10, 2024.

National Cancer Institute website. Thyroid cancer treatment (PDQ) - health professional version. www.cancer.gov/cancertopics/pdq/treatment/thyroid/HealthProfessional. Updated May 9, 2025. Accessed September 24, 2025.

Pearce EN, Hollenberg AN. Thyroid. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 207.

Sipos JA, Haugen BR. Papillary thyroid cancer. In: Randolph GW, ed. Surgery of the thyroid and parathyroid glands. 3rd ed. Philadelphia, PA: Elsevier; 2021:chap. 19.

Thompson LDR. Malignant neoplasms of the thyroid gland. In: Thompson LDR, Bishop JA, eds. Head and Neck Pathology. 3rd ed. Philadelphia, PA: Elsevier; 2019:chap 25.